 BOULDER, Colo., Nov. 16, 2020 GLOBE NEWSWIRE -- Brickell Biotech, Inc. Brickell Nasdaq: BBI, a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that its management team will participate in the Piper Sandler 32nd Annual Healthcare Conference taking place December 1-3, 2020. 